Gainers Recap: Anika Therapeutics, Chinacast Education Corporation, Netlist, Inc. (NASDAQ:NLST), Natus Medical Inc

Lakeway, NY -- (SBWIRE) -- 03/01/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Anika Therapeutics, Inc. (NASDAQ:ANIK) soared 16.25% and closed at $12.45. The Company reported fourth quarter results. Anika's total revenue increased 23% to $22.6 million in the fourth quarter of 2012. Operating income for the fourth quarter of 2012 was $7.8 million from $4.9 million in the same period in 2011. Net income for the fourth quarter of 2012 was $4.5 million or $0.31 per diluted share from $2.9 million or $0.21 per diluted share in the fourth quarter last year.

How Should Investors Trade ANIK After The Recent Price movement? Find out Here

Chinacast Education Corporation (PINK: CAST) moved up 14.19% and closed at $0.12. A group of U.S. investment funds has sued the Chinese and U.S. affiliates of Deloitte Touche Tohmatsu, blaming them for investor losses at troubled ChinaCast Education Corp. The funds are seeking to recover tens of millions of dollars of investment losses from Deloitte, which audited the Chinese company's financial statements. The lawsuit was filed in U.S. District Court in Manhattan.

Is CAST a Strong Buying Opportunity After The Recent Slump? Find out Here

Netlist, Inc. (NASDAQ:NLST) soared 11.43% and closed at $0.78.Netlist, Inc. announced that its 32GB HyperCloud HCDIMM memory was an integral part of a system which broke the one million transactions per minute barrier in TPC Benchmark C testing.Netlist, Inc. designs and manufactures high-performance, logic-based memory subsystems for server and storage applications for cloud computing.

How Should Investors Trade NLST After The Recent Price movement? Find out Here

Natus Medical Inc. (NASDAQ:BABY) soared 10.82% and closed at $12.70. The Company reported fourth quarter and year end results. The revenue was $90.5 million compared to $64.1 million reported in the comparable quarter of the previous year. The Company reported net income of $4.8 million or $0.16 per diluted share for the fourth quarter 2012compared to a loss of $17.3 million, or loss of $0.61 per share for the fourth quarter of 2011. For the year ended December 31, 2012, Natus reported revenue of $291.7 million, compared to $232.7 million reported in 2011.

How Should Investors Trade BABY After The Recent Price movement? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.